Literature DB >> 27725851

BMP2 promotes the differentiation of neural stem cells into dopaminergic neurons in vitro via miR-145-mediated upregulation of Nurr1 expression.

Wang Yan1, Zhao-Ying Chen1, Jia-Qi Chen1, Hui-Min Chen1.   

Abstract

BACKGROUND: Neural stem cells (NSCs) are pluripotent and self-renewing cells which could differentiate into diverse types of neural cells, such as dopaminergic (DA) neurons, the loss of which is the typical characteristic of Parkinson's disease (PD). This study aimed to examine the molecular mechanisms of BMP2-mediating NSCs differentiation into DA neurons.
METHODS: Different concentrations of BMP2 were used to induce the differentiation of NSCs into DA neurons, which were characterized by the number and the neurite lengths of tyrosine hydroxylase (TH)+ and dopamine transporter (DAT)+ neurons by immunocytochemistry. qRT-PCR and Western blot were performed to explore the expression of miR-145 and Nurr1. The methylation level of miR-145 promoter was examined by DNA methylation analyses. The regulation of miR-145 on Nurr1 was detected by Dual-Luciferase reporter assay.
RESULTS: The number of TH+ and DAT+ neurons were significantly increased in NSCs treated with 20 and 100 ng/ml of BMP2, as well as the neurite lengths of TH+ and DAT+ neurons. The reduced level of miR-145 and up-regulated Nurr1 were observed in NSCs induced by BMP2. The hypermethylation level of miR-145 promoter down-regulated the expression of miR-145 in NSCs pretreated with BMP2, which was regulated by DNMT3b. Luciferase reporter assay showed that Nurr1 was a direct target of miR-145. miR-145 overexpression restrained the differentiating effect of BMP2. Moreover, overexpression of Nurr1 abrogated this effect of miR-145 overexpression.
CONCLUSION: Our results showed that BMP2 promoted the differentiation of NSCs into DA neurons in vitro and miR-145 and Nurr1 were involved in the neurotrophic effects of BMP2.

Entities:  

Keywords:  BMP2; Neural stem cells; Nurr1; differentiation; dopaminergic neurons; miR-145

Year:  2016        PMID: 27725851      PMCID: PMC5040669     

Source DB:  PubMed          Journal:  Am J Transl Res            Impact factor:   4.060


  36 in total

1.  BMPs inhibit neurogenesis by a mechanism involving degradation of a transcription factor.

Authors:  J Shou; P C Rim; A L Calof
Journal:  Nat Neurosci       Date:  1999-04       Impact factor: 24.884

2.  down-regulation of Kruppel-like factor-4 (KLF4) by microRNA-143/145 is critical for modulation of vascular smooth muscle cell phenotype by transforming growth factor-beta and bone morphogenetic protein 4.

Authors:  Brandi N Davis-Dusenbery; Mun Chun Chan; Kelsey E Reno; Alexandra S Weisman; Matthew D Layne; Giorgio Lagna; Akiko Hata
Journal:  J Biol Chem       Date:  2011-06-13       Impact factor: 5.157

3.  Serotonergic neurons mediate dyskinesia side effects in Parkinson's patients with neural transplants.

Authors:  Marios Politis; Kit Wu; Clare Loane; Niall P Quinn; David J Brooks; Stig Rehncrona; Anders Bjorklund; Olle Lindvall; Paola Piccini
Journal:  Sci Transl Med       Date:  2010-06-30       Impact factor: 17.956

4.  Mesenchymal stem cells deliver exogenous miRNAs to neural cells and induce their differentiation and glutamate transporter expression.

Authors:  Hae Kyung Lee; Susan Finniss; Simona Cazacu; Cunli Xiang; Chaya Brodie
Journal:  Stem Cells Dev       Date:  2014-09-22       Impact factor: 3.272

5.  A feedback regulation between miR-145 and DNA methyltransferase 3b in prostate cancer cell and their responses to irradiation.

Authors:  Gang Xue; Zhenxin Ren; Yaxiong Chen; Jiayun Zhu; Yarong Du; Dong Pan; Xiaoman Li; Burong Hu
Journal:  Cancer Lett       Date:  2015-03-05       Impact factor: 8.679

Review 6.  TGFβ signalling in context.

Authors:  Joan Massagué
Journal:  Nat Rev Mol Cell Biol       Date:  2012-09-20       Impact factor: 94.444

7.  A role for miR-145 in pulmonary arterial hypertension: evidence from mouse models and patient samples.

Authors:  Paola Caruso; Yvonne Dempsie; Hannah C Stevens; Robert A McDonald; Lu Long; Ruifang Lu; Kevin White; Kirsty M Mair; John D McClure; Mark Southwood; Paul Upton; Mei Xin; Eva van Rooij; Eric N Olson; Nicholas W Morrell; Margaret R MacLean; Andrew H Baker
Journal:  Circ Res       Date:  2012-06-19       Impact factor: 17.367

8.  Bone morphogenetic proteins: neurotrophic roles for midbrain dopaminergic neurons and implications of astroglial cells.

Authors:  J Jordan; M Böttner; H J Schluesener; K Unsicker; K Krieglstein
Journal:  Eur J Neurosci       Date:  1997-08       Impact factor: 3.386

9.  Establishing embryonic mouse neural stem cell culture using the neurosphere assay.

Authors:  Hassan Azari; Sharareh Sharififar; Maryam Rahman; Saeed Ansari; Brent A Reynolds
Journal:  J Vis Exp       Date:  2011-01-11       Impact factor: 1.355

10.  Behavioral improvement in a primate Parkinson's model is associated with multiple homeostatic effects of human neural stem cells.

Authors:  D Eugene Redmond; Kimberly B Bjugstad; Yang D Teng; Vaclav Ourednik; Jitka Ourednik; Dustin R Wakeman; Xuejun H Parsons; Rodolfo Gonzalez; Barbara C Blanchard; Seung U Kim; Zezong Gu; Stuart A Lipton; Eleni A Markakis; Robert H Roth; John D Elsworth; John R Sladek; Richard L Sidman; Evan Y Snyder
Journal:  Proc Natl Acad Sci U S A       Date:  2007-06-22       Impact factor: 11.205

View more
  9 in total

Review 1.  Emerging roles of microRNAs in intestinal ischemia/reperfusion-induced injury: a review.

Authors:  Ghaidafeh Akbari
Journal:  J Physiol Biochem       Date:  2020-11-03       Impact factor: 4.158

Review 2.  Targeting bone morphogenetic protein signalling in midbrain dopaminergic neurons as a therapeutic approach in Parkinson's disease.

Authors:  Gerard W O'Keeffe; Shane V Hegarty; Aideen M Sullivan
Journal:  Neuronal Signal       Date:  2017-03-31

Review 3.  The potential of bone morphogenetic protein 2 as a neurotrophic factor for Parkinson's disease.

Authors:  Susan R Goulding; Aideen M Sullivan; Gerard W O'Keeffe; Louise M Collins
Journal:  Neural Regen Res       Date:  2020-08       Impact factor: 5.135

4.  Altered Nurr1 protein expression in the hippocampal CA1 region following transient global cerebral ischemia.

Authors:  Joon Ha Park; Ji Hyeon Ahn; Dae Won Kim; Tae-Kyeong Lee; Cheol Woo Park; Young Eun Park; Jae-Chul Lee; Hyang-Ah Lee; Go Eun Yang; Moo-Ho Won; Choong-Hyun Lee
Journal:  Mol Med Rep       Date:  2019-11-20       Impact factor: 2.952

5.  Change of Nurr1 expression in mouse hippocampal CA3 region following excitotoxic neuronal damage.

Authors:  Choong-Hyun Lee
Journal:  Iran J Basic Med Sci       Date:  2020-02       Impact factor: 2.699

6.  Inhibition of lysine-specific demethylase 1A suppresses neointimal hyperplasia by targeting bone morphogenetic protein 2 and mediating vascular smooth muscle cell phenotype.

Authors:  Xiaobo Zhang; Tao Huang; Heng Zhai; Wenpeng Peng; Yong Zhou; Qi Li; Haifeng Yang
Journal:  Cell Prolif       Date:  2019-11-18       Impact factor: 6.831

7.  Inhibition of miR-145-5p Reduces Spinal Cord Injury-Induced Inflammatory and Oxidative Stress Responses via Affecting Nurr1-TNF-α Signaling Axis.

Authors:  Lei Jiang; Zeng-Chun Wei; Li-Li Xu; Shan-Ying Yu; Chao Li
Journal:  Cell Biochem Biophys       Date:  2021-06-16       Impact factor: 2.194

8.  miR-381-3p knockdown improves intestinal epithelial proliferation and barrier function after intestinal ischemia/reperfusion injury by targeting nurr1.

Authors:  Liwei Liu; Jihong Yao; Zhenlu Li; Guo Zu; Dongcheng Feng; Yang Li; Wasim Qasim; Su Zhang; Tong Li; Huizhi Zeng; Xiaofeng Tian
Journal:  Cell Death Dis       Date:  2018-03-14       Impact factor: 8.469

Review 9.  Epigenetic Regulations in Neural Stem Cells and Neurological Diseases.

Authors:  Hang Zhou; Bin Wang; Hao Sun; Xingshun Xu; Yongxiang Wang
Journal:  Stem Cells Int       Date:  2018-03-18       Impact factor: 5.443

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.